MAP2K1 and melanoma: Therefore, we performed cytotoxicity assays using freshly purified resting allogenic NK cells as effectors, and AMM16 (Fig. 4C, D), WM266-4 (Fig. 4E, F) or LCM-MEL (Fig. 4G, H) melanoma cells as targets.